Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kirkpatrick

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Ebiomedicine|March 13, 2019
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection modelUsha K Nivarthi, Huy A Tu, Matthew J Delacruz, et al.
Nature Communications|February 14, 2026
Causes and consequences of experimental variation in Nicotiana benthamiana transient expressionSophia N Tang, Matthew J Szarzanowicz, Amy Lanctot, et al.
The Journal of Infectious Diseases|February 2, 2018
Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine EfficacyBenjamin Lee, Dorothy M Dickson, Allan C deCamp, et al.
The American Journal of Tropical Medicine and Hygiene|May 13, 2020
Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical TrialAnna P Durbin, Kristen K Pierce, Beth D Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2016
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El TorWilbur H Chen, Mitchell B Cohen, Beth D Kirkpatrick, et al.
Journal of Hepatology|August 1, 2024
Transposon-based oncogene integration in Abcb4(Mdr2)<sup>-/-</sup> mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitisPinzhu Huang, Guangyan Wei, Jesse D Kirkpatrick, et al.
The Lancet. Infectious Diseases|September 30, 2023
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trialMary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, et al.
The Journal of Infectious Diseases|March 12, 2020
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in BangladeshFrank B Williams, Abdul Kader, E Ross Colgate, et al.
Cell Reports|January 25, 2026
Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASHKenneth Li, Vardhman Kumar, Tran To, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Ebiomedicine|March 13, 2019
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection modelUsha K Nivarthi, Huy A Tu, Matthew J Delacruz, et al.
Nature Communications|February 14, 2026
Causes and consequences of experimental variation in Nicotiana benthamiana transient expressionSophia N Tang, Matthew J Szarzanowicz, Amy Lanctot, et al.
The Journal of Infectious Diseases|February 2, 2018
Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine EfficacyBenjamin Lee, Dorothy M Dickson, Allan C deCamp, et al.
The American Journal of Tropical Medicine and Hygiene|May 13, 2020
Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical TrialAnna P Durbin, Kristen K Pierce, Beth D Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2016
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El TorWilbur H Chen, Mitchell B Cohen, Beth D Kirkpatrick, et al.
Journal of Hepatology|August 1, 2024
Transposon-based oncogene integration in Abcb4(Mdr2)<sup>-/-</sup> mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitisPinzhu Huang, Guangyan Wei, Jesse D Kirkpatrick, et al.
The Lancet. Infectious Diseases|September 30, 2023
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trialMary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, et al.
The Journal of Infectious Diseases|March 12, 2020
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in BangladeshFrank B Williams, Abdul Kader, E Ross Colgate, et al.
Cell Reports|January 25, 2026
Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASHKenneth Li, Vardhman Kumar, Tran To, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Pageof 34